We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $8.17B
1-Year Est. Return 68.82%
This Fund
S&P 500
This Quarter Est. Return
+1.37%
1 Year Est. Return
+68.82%
3 Year Est. Return
+79.68%
5 Year Est. Return
+64.24%
10 Year Est. Return
+259.8%
AUM
$5.76B
AUM Growth
+$32.7M
Cap. Flow
+$188M
Cap. Flow %
3.27%
Top 10 Hldgs %
50.49%
Holding
248
New
70
Increased
46
Reduced
39
Closed
50

Top Buys

Rank Stock Value
1
GSK icon
GSK
GSK
+$136M
2
FRPT icon
Freshpet
FRPT
+$91.3M
3
ROST icon
Ross Stores
ROST
+$81.3M
4
FIVE icon
Five Below
FIVE
+$72.6M
5
EXAS
Exact Sciences
EXAS
+$64.3M

Top Sells

Rank Stock Value
1
DG icon
Dollar General
DG
+$75.6M
2
CPRX
Catalyst Pharmaceutical
CPRX
+$71.5M
3
ILMN icon
Illumina
ILMN
+$62.5M
4
AZN icon
AstraZeneca
AZN
+$55.2M
5
TSCO icon
Tractor Supply
TSCO
+$51.8M

Sector Composition

Rank Sector Weight
1 Healthcare 43.48%
2 Miscellaneous 31.17%
3 Consumer Discretionary 9.47%
4 Consumer Staples 8.21%
5 Technology 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ISEE
51
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$24.5M 0.42%
+1,364,000
New +$17.9M
PFE icon
52
Pfizer
PFE
$159B
$23.5M 0.41%
536,000
+80,000
+18% +$3.89M
EVBG
53
DELISTED
Everbridge, Inc. Common Stock
EVBG
$23.3M 0.4%
756,000
+220,000
+41% +$7.22M
UBER icon
54
Uber
UBER
$149B
$22.2M 0.38%
836,000
-1,164,000
-58% -$32.2M
CL icon
55
Colgate-Palmolive
CL
$70.5B
$22.1M 0.38%
315,000
-157,000
-33% -$12.3M
ATEC icon
56
Alphatec Holdings
ATEC
$1.42B
$21.3M 0.37%
2,436,000
-488,000
-17% -$3.86M
MGNX icon
57
MacroGenics
MGNX
$273M
$21.2M 0.37%
6,128,000
– –
BNTX icon
58
BioNTech
BNTX
$24.9B
$21M 0.37%
156,000
+56,000
+56% +$8.56M
VYGR icon
59
Voyager Therapeutics
VYGR
$214M
$20.1M 0.35%
3,396,000
+832,000
+32% +$5.33M
TOST icon
60
Toast
TOST
$19.2B
$19.5M 0.34%
1,164,000
-308,000
-21% -$5.34M
DLTR icon
61
Dollar Tree
DLTR
$23.3B
$18.4M 0.32%
+135,535
New +$21.1M
TSVT
62
DELISTED
2seventy bio
TSVT
$18.4M 0.32%
1,264,000
-336,000
-21% -$4.99M
EL icon
63
Estee Lauder
EL
$36.9B
$16.8M 0.29%
+78,000
New +$19.9M
SHOP icon
64
Shopify
SHOP
$172B
$16.8M 0.29%
625,000
+385,000
+160% +$13.1M
SCPH
65
DELISTED
scPharmaceuticals
SCPH
$16.2M 0.28%
2,492,000
-208,000
-8% -$1.11M
IMCR icon
66
Immunocore
IMCR
$1.82B
$14.8M 0.26%
316,000
+48,000
+18% +$2.29M
AVTX icon
67
Avalo Therapeutics
AVTX
$1.07B
$13.2M 0.23%
16,519
– –
JNJ icon
68
Johnson & Johnson
JNJ
$651B
$13.1M 0.23%
80,000
-176,000
-69% -$29.8M
PANW icon
69
Palo Alto Networks
PANW
$275B
$12.6M 0.22%
153,600
+81,600
+113% +$7.07M
UNH icon
70
UnitedHealth
UNH
$361B
$12.1M 0.21%
24,000
-26,000
-52% -$13.7M
FDX icon
71
FedEx
FDX
$75B
$11.9M 0.21%
+80,000
New +$16.9M
DDOG icon
72
Datadog
DDOG
$74.9B
$11.4M 0.2%
128,000
+58,000
+83% +$5.84M
CROX icon
73
Crocs
CROX
$5.48B
$11.1M 0.19%
+161,800
New +$11.2M
SWAV
74
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$10M 0.17%
+36,000
New +$9.15M
FREE
75
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
$9.2M 0.16%
2,395,802
+439,802
+22% +$2.4M
1 2
3
4 5

Similar funds

MWM
Mission Wealth Management Santa Barbara, California $8.18B AUM 28.28% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return
SC
Saturna Capital Bellingham, Washington $8.19B AUM 42.01% 1-Year Est. Return
SFM
Soros Fund Management New York $8.14B AUM 35.85% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
BIM
Bridges Investment Management Omaha, Nebraska $8.22B AUM 21.38% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return

Armistice Capital's Q3 2022 Portfolio in Review

As of Q3 2022, Armistice Capital held 248 positions worth $5.76B, up 0.57% from $5.73B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Armistice Capital deployed $188M of net new capital in Q3 2022, opening 70 new positions and adding to 46 existing holdings. Its largest new stake was GSK: 3,600,000 shares worth $106M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 44% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $46.6M trimmed.

  • Armistice Capital's largest Q3 2022 buy was GSK: 3,600,000 shares worth $106M.
  • Armistice Capital added most to Freshpet in Q3 2022, an estimated $91.3M increase.
  • Armistice Capital's biggest Q3 2022 reduction was Vertex Pharmaceuticals, cutting an estimated $46.6M.
  • Armistice Capital fully exited Dollar General in Q3 2022, selling an estimated $75.6M.
  • Armistice Capital's ten largest holdings make up 50% of its $5.76B portfolio in Q3 2022.
  • Armistice Capital opened 70 new positions and closed 50 in Q3 2022.
  • Armistice Capital's portfolio value rose 0.57% quarter-over-quarter to $5.76B.

Based on Armistice Capital's 13F filing for Q3 2022, filed 14 Nov 2022.